Charles River Labs (CRL) Stock Forecast & Price Target
CRL Analyst Ratings
Strong Buy
14Buy1Hold0Sell
Based on 15 analysts giving stock ratings to Charles River Labs in the past 3 months
CRL Stock 12 Month Forecast
Average Price Target
MXN 6,228.21▼(-5.06% Downside)Based on 15 Wall Street analysts offering 12 month price targets for Charles River Labs in the last 3 months. The average price target is MXN 6,228.21 with a high forecast of MXN 6,740.94 and a low forecast of MXN 5,570.24. The average price target represents a -5.06% change from the last price of MXN 6,559.90.
Past 12 Months12 Month ForecastDec2025Sep2026
HighMXN 6.74K
AverageMXN 6.23K
LowMXN 5.57K
Highest Price TargetHighestMXN 6,740.94Average Price TargetMXN 6,228.21Lowest Price TargetLowestMXN 5,570.24
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Casey Woodring | J.P. Morgan | MXN 5,853.47→MXN 6,514.35 | buy | -0.69%Downside | Reiterated | 10/16/26 | ||
| Kallum Titchmarsh | Morgan Stanley | MXN 5,664.65→MXN 6,419.94 | buy | -2.13%Downside | Assigned | 10/13/26 | ||
| Ryan Halsted | RBC Capital | MXN 6,080.06 | buy | -7.31%Downside | Reiterated | 10/06/26 | ||
| Kevin Caliendo | UBS | MXN 6,740.94 | buy | 2.76%Upside | Initiated | 09/30/26 | ||
| David Windley | Jefferies | MXN 5,759.06→MXN 6,419.94 | buy | -2.13%Downside | Reiterated | 09/28/26 | ||
| Michael Ryskin | Bank of America Securities | ― | buy | ― | Reiterated | 09/28/26 | ||
| Charles Rhyee | TD Cowen | MXN 5,664.65→MXN 6,136.71 | buy | -6.45%Downside | Assigned | 09/25/26 | ||
| Eric Coldwell | Robert W. Baird | MXN 5,494.71→MXN 6,306.65 | buy | -3.86%Downside | Reiterated | 09/25/26 | ||
| Ann Hynes | Mizuho Securities | MXN 4,984.89→MXN 5,570.24 | hold | -15.09%Downside | Reiterated | 09/25/26 | ||
| Elizabeth Anderson CFA | Evercore ISI | MXN 6,042.30→MXN 6,231.12 | buy | -5.01%Downside | Reiterated | 09/25/26 | ||
| Justin Bowers | Deutsche Bank | MXN 5,664.65→MXN 6,042.30 | buy | -7.89%Downside | Assigned | 09/25/26 | ||
| Jared Haase | William Blair | ― | buy | ― | Reiterated | 09/24/26 | ||
| Luke Sergott | Barclays | MXN 5,664.65→MXN 6,231.12 | buy | -5.01%Downside | Reiterated | 09/24/26 | ||
 Unknown AnalystNot Ranked | Stephens | MXN 6,042.30 | buy | -7.89%Downside | Initiated | 09/22/26 | ||
| David Toung | Argus Research | MXN 4,720.54→MXN 6,231.12 | buy | -5.01%Downside | Assigned | 09/16/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Casey Woodring | 10/16/26 | MXN 5,853.47→MXN 6,514.35 | buy | -0.69%Downside | Reiterated | J.P. Morgan | ||
| Kallum Titchmarsh | 10/13/26 | MXN 5,664.65→MXN 6,419.94 | buy | -2.13%Downside | Assigned | Morgan Stanley | ||
| Ryan Halsted | 10/06/26 | MXN 6,080.06 | buy | -7.31%Downside | Reiterated | RBC Capital | ||
| Kevin Caliendo | 09/30/26 | MXN 6,740.94 | buy | 2.76%Upside | Initiated | UBS | ||
| David Windley | 09/28/26 | MXN 5,759.06→MXN 6,419.94 | buy | -2.13%Downside | Reiterated | Jefferies | ||
| Michael Ryskin | 09/28/26 | ― | buy | ― | Reiterated | Bank of America Securities | ||
| Charles Rhyee | 09/25/26 | MXN 5,664.65→MXN 6,136.71 | buy | -6.45%Downside | Assigned | TD Cowen | ||
| Eric Coldwell | 09/25/26 | MXN 5,494.71→MXN 6,306.65 | buy | -3.86%Downside | Reiterated | Robert W. Baird | ||
| Ann Hynes | 09/25/26 | MXN 4,984.89→MXN 5,570.24 | hold | -15.09%Downside | Reiterated | Mizuho Securities | ||
| Elizabeth Anderson CFA | 09/25/26 | MXN 6,042.30→MXN 6,231.12 | buy | -5.01%Downside | Reiterated | Evercore ISI | ||
| Justin Bowers | 09/25/26 | MXN 5,664.65→MXN 6,042.30 | buy | -7.89%Downside | Assigned | Deutsche Bank | ||
| Jared Haase | 09/24/26 | ― | buy | ― | Reiterated | William Blair | ||
| Luke Sergott | 09/24/26 | MXN 5,664.65→MXN 6,231.12 | buy | -5.01%Downside | Reiterated | Barclays | ||
| Unknown AnalystNot Ranked | 09/22/26 | MXN 6,042.30 | buy | -7.89%Downside | Initiated | Stephens | ||
| David Toung | 09/16/26 | MXN 4,720.54→MXN 6,231.12 | buy | -5.01%Downside | Assigned | Argus Research |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Charles River Labs
3 Months
Success Rate9/14 ratings generated profit
64%
Average Return
+8.47%
Copying Patrick B Donnelly's trades and holding each position for 3 Months would result in 64.29% of your transactions generating a profit, with an average return of +8.47% per trade.
1 Year
Success Rate35/44 ratings generated profit
80%
Average Return
+21.70%
Copying David Windley's trades and holding each position for 1 Year would result in 79.55% of your transactions generating a profit, with an average return of +21.70% per trade.
2 Years
Success Rate35/44 ratings generated profit
80%
Average Return
+29.11%
Copying David Windley's trades and holding each position for 2 Years would result in 79.55% of your transactions generating a profit, with an average return of +29.11% per trade.
CRL Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 19 | 19 | 19 | 29 | 29 |
| Hold | 4 | 5 | 4 | 4 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 23 | 24 | 23 | 33 | 31 |
In the current month, CRL has received 29 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. CRL average Analyst price target in the past 3 months is 6,228.21.
CRL Financial Forecast
HighMXN 58.05
ConsensusMXN 55.83
LowMXN 55.06
CRL Earnings Forecast
Next quarter’s earnings estimate for CRL is MXN 55.83 with a range of MXN 55.06 to MXN 58.05. The previous quarter’s EPS was MXN 56.75. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighMXN 18.5B
ConsensusMXN 18B
LowMXN 17.9B
CRL Sales Forecast
Next quarter’s sales forecast for CRL is MXN 18.05B with a range of MXN 17.88B to MXN 18.50B. The previous quarter’s sales results were MXN 18.87B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
CRL Stock Forecast FAQ
What is MX:CRL’s average 12-month price target, according to analysts?
Based on analyst ratings, Charles River Labs’s 12-month average price target is Mex$6,228.21.
What is MX:CRL’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for MX:CRL, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Charles River Labs a Buy, Sell or Hold?
Charles River Labs has a consensus rating of Strong Buy, which is based on 14 buy ratings, 1 hold ratings and 0 sell ratings.
What is Charles River Labs’s share price target?
The average share price target for Charles River Labs is Mex$6,228.21. This is based on 15 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is Mex$6,740.94, and the lowest forecast is Mex$5,570.24. The average share price target represents a 5.06% decrease from the current price of Mex$6,559.9.
What do analysts say about Charles River Labs?
Charles River Labs’s analyst rating consensus is a Strong Buy. This is based on the ratings of 15 Wall Street analysts.
How can I buy shares of Charles River Labs?
To buy shares of MX:CRL, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
